All Articles

Bliss Baby brings its 'spa-level' care to Walmart. We analyze the strategy, from its generational appeal to its high-stakes bet on premiumizing the mass market.

A Florida lender's tech-fueled success reveals a paradigm shift in mortgages, proving the best new business is the business you already have closed.

In a market driven by pet humanization, Carlson Pet Products’ ‘Brand of the Year’ award reveals a winning strategy: durable, affordable innovation over fleeting trends.

The security giant wins "Great Place to Work" again, but in an industry with 89% turnover, can corporate accolades truly reflect the reality on the ground?

Beyond simple automation, banks and retailers are now orchestrating a blended workforce of humans, bots, and AI agents to redefine efficiency and service.

Delcath Systems posts strong revenue and profits, but the real story is its massive investment in expanding its unique liver therapy to fight breast cancer and more.

An award-winning F1 campaign was more than a spectacle. It launched Data Experience Management, a new category aiming to fix the auto industry's fragmented data.

vTv Therapeutics is nearing a critical milestone with its oral drug for Type 1 diabetes. Can it solve a deadly problem while navigating the financial tightrope?

Levelwear's new NFL deal completes its sports empire. But its true goal may be to change how we wear our loyalty, one premium, lifestyle garment at a time.

Kickstarter pivots with a $1M Culture Fund, directly investing in creators. This move marks a strategic shift from facilitator to active patron. What does it mean?

Dolby's new Dolby Vision 2, launching first on Hisense TVs, isn't just another spec bump. It's an intelligent system designed to restore artistic intent and adapt to your life.

A new clinical trial is testing a novel oncolytic virus, VCN-01, to break down pancreatic cancer's defenses, a key step toward a pivotal therapy.

A $25k grant from a tech company to a biotech startup reveals a powerful new model for industrial transformation, targeting the hidden plastic in our food system.

A tech firm's $25K grant empowers a biotech startup to tackle agriculture's $100B plastic crisis with innovative, compostable seaweed materials.

With new patents and a $300M war chest, Beren Therapeutics nears an FDA decision for its NPC drug. But can its public benefit model survive the high-risk biotech gauntlet?

July saw 4.35 billion robocalls, the highest in a year. Nearly half were scams, signaling a sophisticated assault on consumers and an escalating data war.

The media giant posts a second straight profitable quarter, but a closer look reveals a strategy built on deep cuts and a shrinking user base.

Shueisha's free MANGA MILLION platform is a centennial celebration, but a closer look reveals a strategic pivot with major questions about AI and creative labor.

Amphenol's stock split and dividend aren't just financial housekeeping. They're a bold signal of confidence in the booming tech hardware market. Here's why.

Beyond the clinical data, ALX Oncology's latest update reveals a masterclass in strategic finance and leadership, positioning it for critical milestones.